Condition
Menopause Hot Flashes clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Menopause Hot Flashes clinical trials that are recruiting, at sites in 2 countries (most in United States (4), Brazil (1)). By phase: Phase 2/3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Menopause Hot Flashes clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Cooling to see if targeted or ambient cooling reduces menopausal hot flashes | — | Menlo Park, California | Recruiting | Sep 17, 2026 |
| Dietary guidelines-based eating plan to reduce menopausal symptoms in overweight and obese women | — | Porto Alegre, Rio Grande do Sul | Recruiting | Sep 16, 2026 |
| Haelan 951 for menopause symptoms in peri- and postmenopausal women | — | Kansas City, Missouri | Recruiting | Aug 6, 2026 |
| Tirzepatide for hot flashes and biological aging in postmenopausal women with obesity | Phase 4 | Jacksonville, Florida | Recruiting | Oct 20, 2025 |
| Improving midlife women's health during the menopausal transition | Phase 2/3 | Aurora, Colorado and 2 other locations | Recruiting | May 16, 2025 |
All recruiting trials (5)
-
Cooling to see if targeted or ambient cooling reduces menopausal hot flashes
This study tests whether targeted skin cooling or ambient cooling can lessen hot flashes in midlife women who are menopausal or in transition.
-
Dietary guidelines-based eating plan to reduce menopausal symptoms in overweight and obese women
A randomized trial will test whether following healthy eating guidance from Brazil’s dietary guidelines can lessen menopausal symptoms in women who are overweight or obese.
-
Haelan 951 for menopause symptoms in peri- and postmenopausal women
This open-label study tests daily Haelan 951, a fermented soy product, to see if it helps with hot flashes, sleep, and quality of life in peri- and postmenopausal women.
-
Tirzepatide for hot flashes and biological aging in postmenopausal women with obesity
This trial will test whether tirzepatide reduces bothersome hot flashes and improves measures of biological aging in postmenopausal women with obesity.
-
Improving midlife women's health during the menopausal transition
This study will test whether medicines (metformin, semaglutide, blood pressure and cholesterol drugs) combined with lifestyle changes can reduce bothersome menopausal symptoms and lower future heart and metabolic disease risk in women aged 45–55 who are in the late menopausal transition.
Related topics
Quick answers
How many Menopause Hot Flashes clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.